Advertisement
Screener

Onconetix, Inc. (ONCO) Form D

Onconetix, Inc. Form D Notices of Exempt Offering of Securities

Notices filed with the SEC for securities sold without registration under Regulation D or Section 4(a)(5), newest first. Values are as filed.

  • 2025-10-07: Federal exemption Rule 506(b); Types of securities offered Equity; Debt; OptionToAcquire; SecurityToBeAcquired; Date of first sale 2025-09-22; Total offering amount $12,977,670.
  • 2024-10-17: Federal exemption Rule 506(b); Types of securities offered Equity; Debt; SecurityToBeAcquired; Date of first sale 2024-10-02; Total offering amount $2,000,000.
FiledFederal exemptionTypes of securities offeredDate of first saleTotal offering amountTotal amount soldTotal remaining to be soldInvestors who have already invested
2025-10-07Rule 506(b)Equity; Debt; OptionToAcquire; SecurityToBeAcquired2025-09-22$12,977,670$12,977,670$011
2024-10-17Rule 506(b)Equity; Debt; SecurityToBeAcquired2024-10-02$2,000,000$2,000,000$05

Similar stocks

Stock NameCountryMarket CapPE Ratio
HCW Biologics Inc. (HCWB)United States$0.004B-6.15
REVELATION BIOSCIENCES, INC. (REVB)United States$0.004B
Aptevo Therapeutics Inc. (APVO)United States$0.003B
Sunshine Biopharma Inc. (SBFM)$0.003B
60 DEGREES PHARMACEUTICALS, INC. (SXTP)United States$0.004B-0.59
Alaunos Therapeutics, Inc. (TCRT)United States$0.003B-1.44
Genprex, Inc. (GNPX)United States$0.003B-0.02
Silo Pharma, Inc. (SILO)United States$0.003B-1.57
Lakewood-Amedex Biotherapeutics Inc. (LABT)United States$0.004B
Cadrenal Therapeutics, Inc. (CVKD)United States$0.004B-0.90